Abstract
Multiple sclerosis (MS) is an autoimmune disease accompanied with nerve pain and paralysis. Although various pathogenic causes of MS have been suggested, including genetic and environmental factors, how MS occurs remains unclear. Moreover, MS should be diagnosed based on clinical experiences because of no disease-specific biomarker and currently available treatments for MS just can reduce relapsing frequency or severity with little effects on disease disability. Therefore, more efforts are required to identify pathophysiology of MS and diagnosis markers. Recent evidence indicates another aspect of MS pathogenesis, energy failure in the central nervous system (CNS). For instance, inflammation that is a characteristic MS symptom and occurs frequently in the CNS of MS patients can result into energy failure in mitochondria and cytosol. Indeed, metabolomics studies for MS have reported energy failure in oxidative phosphorylation and alteration of aerobic glycolysis. Therefore, studies on the metabolism in the CNS may provide another insight for understanding complexity of MS and pathogenesis, which would facilitate the discovery of promising strategies for developing therapeutics to treat MS. This review will provide an overview on recent progress of metabolomic studies for MS, with a focus on the fluctuation of energy metabolism in MS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allaman I, Fiumelli H, Magistretti PJ, Martin JL (2011) Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology 216:75–84. https://doi.org/10.1007/s00213-011-2190-y
Andersen SL, Briggs FBS, Winnike JH, Natanzon Y, Maichle S, Knagge KJ, Newby LK, Gregory SG (2019) Metabolome-based signature of disease pathology in MS. Mult Scler Relat Disord 31:12–21. https://doi.org/10.1016/j.msard.2019.03.006
Araque A, Carmignoto G, Haydon PG, Oliet SH, Robitaille R, Volterra A (2014) Gliotransmitters travel in time and space. Neuron 81:728–39. https://doi.org/10.1016/j.neuron.2014.02.007
Ashrafi G, Wu Z, Farrell RJ, Ryan TA (2017) GLUT4 mobilization supports energetic demands of active synapses. Neuron 93:606-615.e3. https://doi.org/10.1016/j.neuron.2016.12.020
Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337–341. https://doi.org/10.1126/science.1198469
Beal MF (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366:211–223. https://doi.org/10.1016/s0005-2728(98)00114-5
Benarroch EE (2017) Nrf2, cellular redox regulation, and neurologic implications. Neurology 88:1942–1950. https://doi.org/10.1212/WNL.0000000000003946
Bernier LP, York EM, Kamyabi A, Choi HB, Weilinger NL, MacVicar BA (2020) Microglial metabolic flexibility supports immune surveillance of the brain parenchyma. Nat Commun 11:1559. https://doi.org/10.1038/s41467-020-15267-z
Beyer BA, Fang M, Sadrian B, Montenegro-Burke JR, Plaisted WC, Kok BPC, Saez E, Kondo T, Siuzdak G, Lairson LL (2018) Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation. Nat Chem Biol 14:22–28. https://doi.org/10.1038/nchembio.2517
Bose S, Ramesh V, Locasale JW (2019) Acetate metabolism in physiology, cancer, and beyond. Trends Cell Biol 29:695–703. https://doi.org/10.1016/j.tcb.2019.05.005
Brown AM, Baltan Tekkök S, Ransom BR (2004) Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem Int 45:529–536. https://doi.org/10.1016/j.neuint.2003.11.005
Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 20:4515–4529. https://doi.org/10.1093/hmg/ddr381
Carlsson H, Abujrais S, Herman S, Khoonsari PE, Åkerfeldt T, Svenningsson A, Burman J, Kultima K (2020) Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry. Metabolomics 16:26. https://doi.org/10.1007/s11306-020-1648-5
Carmans S, Hendriks JJ, Thewissen K, Van den Eynden J, Stinissen P, Rigo JM, Hellings N (2010) The inhibitory neurotransmitter glycine modulates macrophage activity by activation of neutral amino acid transporters. J Neurosci Res 88:2420–30. https://doi.org/10.1002/jnr.22395
Chamberlain KA, Sheng ZH (2019) Mechanisms for the maintenance and regulation of axonal energy supply. J Neurosci Res 97:897–913. https://doi.org/10.1002/jnr.24411
Chang DT, Rintoul GL, Pandipati S, Reynolds IJ (2006) Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 22:388–400. https://doi.org/10.1016/j.nbd.2005.12.007
Chausse B, Kakimoto PA, Kann O (2020) Microglia and lipids: how metabolism controls brain innate immunity. Semin Cell Dev Biol S1084–9521:30197–1. https://doi.org/10.1016/j.semcdb.2020.08.001
Chevalier AC, Rosenberger TA (2017) Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis. J Neurochem 141:721–737. https://doi.org/10.1111/jnc.14032
Chong J, Wishart DS, Xia J (2019) Using metaboanalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr Protoc Bioinform 68:e86. https://doi.org/10.1002/cpbi.86
Ciccarelli O, Barkhof F, Bodini B, De Stefano N, Golay X, Nicolay K, Pelletier D, Pouwels PJ, Smith SA, Wheeler-Kingshott CA, Stankoff B, Yousry T, Miller DH (2014) Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Lancet Neurol 13:807–822. https://doi.org/10.1016/S1474-4422(14)70101-2
Cocco E, Murgia F, Lorefice L, Barberini L, Poddighe S, Frau J, Fenu G, Coghe G, Murru MR, Murru R, Del Carratore F, Atzori L, Marrosu MG (2015) (1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e185. https://doi.org/10.1212/NXI.0000000000000185
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517. https://doi.org/10.1016/S0140-6736(02)08220-X
De Biasi S, Simone AM, Bianchini E, Lo Tartaro D, Pecorini S, Nasi M, Patergnani S, Carnevale G, Gibellini L, Ferraro D, Vitetta F, Pinton P, Sola P, Cossarizza A, Pinti M (2019) Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients. Eur J Immunol 49:2204–2221. https://doi.org/10.1002/eji.201948223
Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545–558. https://doi.org/10.1038/nri3871
Doi M, Yamaoka I, Nakayama M, Sugahara K, Yoshizawa F (2007) Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 292:E1683-E1693. https://doi.org/https://doi.org/10.1152/ajpendo.00609.2006
Ďurfinová M, Bartová R, Orešanská K, Turecký L, Procházková Ľ, Petrleničová D, Líška B (2018) Increased glycine levels in cerebrospinal fluid of patients with multiple sclerosis. Clin Chim Acta 486:86–87. https://doi.org/10.1016/j.cca.2018.07.023
Dutta R, Trapp BD (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68:S22–S31. https://doi.org/10.1212/01.wnl.0000275229.13012.32
Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478–489. https://doi.org/10.1002/ana.20736
Emwas AH, Luchinat C, Turano P, Tenori L, Roy R, Salek RM, Ryan D, Merzaban JS, Kaddurah-Daouk R, Zeri AC, Nagana Gowda GA, Raftery D, Wang Y, Brennan L, Wishart DS (2015) Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics 11:872–894. https://doi.org/10.1007/s11306-014-0746-7
Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D, Li H, Huet G, Yuan Q, Wigal T, Butt Y, Ni M, Torrealba J, Oliver D, Lenkinski RE, Malloy CR, Wachsmann JW, Young JD, Kernstine K, DeBerardinis RJ (2017) Lactate metabolism in human lung tumors. Cell 171:358-371.e9. https://doi.org/10.1016/j.cell.2017.09.019
Fernstrom JD (2005) Branched-chain amino acids and brain function. J Nutr 135:1539S-1546S. https://doi.org/10.1093/jn/135.6.1539S
French CD, Willoughby RE, Pan A, Wong SJ, Foley JF, Wheat LJ, Fernandez J, Encarnacion R, Ondrush JM, Fatteh N, Paez A, David D, Javaid W, Amzuta IG, Neilan AM, Robbins GK, Brunner AM, Hu WT, Mishchuk DO, Slupsky CM (2018) NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system. PLoS Negl Trop Dis 12:e0007045. https://doi.org/10.1371/journal.pntd.0007045
Frisullo G, Nociti V, Iorio R, Patanella AK, Caggiula M, Marti A, Sancricca C, Angelucci F, Mirabella M, Tonali PA, Batocchi AP (2009) Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients. Immunology 127:418–428. https://doi.org/10.1111/j.1365-2567.2008.02963.x
Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517–521. https://doi.org/10.1038/nature11007
Gebregiworgis T, Nielsen HH, Massilamany C, Gangaplara A, Reddy J, Illes Z, Powers R (2016) A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica. J Proteome Res 15:659–666. https://doi.org/10.1021/acs.jproteome.5b01111
Geric I, Schoors S, Claes C, Gressens P, Verderio C, Verfaillie CM, Van Veldhoven PP, Carmeliet P, Baes M (2019) Metabolic Reprogramming during Microglia Activation. Immunometabolism 1:e190002. https://doi.org/10.20900/immunometab20190002
Gnoni GV, Priore P, Geelen MJ, Siculella L (2009) The mitochondrial citrate carrier: metabolic role and regulation of its activity and expression. IUBMB Life 61:987–994. https://doi.org/10.1002/iub.249
Gross CC, Schulte-Mecklenbeck A, Klinsing S, Posevitz-Fejfár A, Wiendl H, Klotz L (2015) Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e183. https://doi.org/10.1212/NXI.0000000000000183
Guillemin GJ (2012) Quinolinic acid, the inescapable neurotoxin. FEBS J 279:1356–1365. https://doi.org/10.1111/j.1742-4658.2012.08485.x
Guillemin GJ, Kerr SJ, Pemberton LA, Smith DG, Smythe GA, Armati PJ, Brew BJ (2001) IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment. J Interferon Cytokine Res 21:1097–1101. https://doi.org/10.1089/107999001317205231
Harris JJ, Jolivet R, Attwell D (2012) Synaptic energy use and supply. Neuron 75:762–777. https://doi.org/10.1016/j.neuron.2012.08.019
Herman S, Åkerfeldt T, Spjuth O, Burman J, Kultima K (2019) Biochemical differences in cerebrospinal fluid between secondary progressive and relapsing remitting multiple sclerosis. Cells 8(2):84. https://doi.org/10.3390/cells8020084
Hertz L, Peng L, Dienel GA (2007) Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab 27:219–249. https://doi.org/10.1038/sj.jcbfm.9600343
Ichihara Y, Doi T, Ryu Y, Nagao M, Sawada Y, Ogata T (2017) Oligodendrocyte progenitor cells directly utilize lactate for promoting cell cycling and differentiation. J Cell Physiol 232: 986-995. https://doi.org/https://doi.org/10.1002/jcp.25690
Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, Cook S, Tankou S, Stuart F, Melo K, Nejad P, Smith K, Topçuolu BD, Holden J, Kivisäkk P, Chitnis T, De Jager PL, Quintana FJ, Gerber GK, Bry L, Weiner HL (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7:12015. https://doi.org/10.1038/ncomms12015
Jewell JL, Kim YC, Russell RC, Yu FX, Park HW, Plouffe SW, Tagliabracci VS, Guan KL (2015) Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science 347:194–198. https://doi.org/10.1126/science.1259472
Jones HH, Jones HH Jr, Bunch LD (1950) Biochemical studies in multiple sclerosis. Ann Intern Med 33:831–840. https://doi.org/10.7326/0003-4819-33-4-831
Jorissen W, Wouters E, Bogie JF, Vanmierlo T, Noben JP, Sviridov D, Hellings N, Somers V, Valcke R, Vanwijmeersch B, Stinissen P, Mulder MT, Remaley AT, Hendriks JJ (2017) Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL. Sci Rep 7:43410. https://doi.org/10.1038/srep43410
Joshi AU, Minhas PS, Liddelow SA, Haileselassie B, Andreasson KI, Dorn GW 2nd, Mochly-Rosen D (2019) Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat Neurosci 22:1635–1648. https://doi.org/10.1038/s41593-019-0486-0
Kapoor R, Davies M, Blaker PA, Hall SM, Smith KJ (2003) Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 53:174–180. https://doi.org/10.1002/ana.10443
Karelson G, Ziegler A, Künnecke B, Seelig J (2003) Feeding versus infusion: a novel approach to study the NAA metabolism in rat brain. NMR Biomed 16:413–423. https://doi.org/10.1002/nbm.845
Kim HH, Jeong IH, Hyun JS, Kong BS, Kim HJ, Park SJ (2017) Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance. PLoS One 12:e0181758. https://doi.org/10.1038/s41598-018-37572-w
Kiryu-Seo S, Kiyama H (2019) Mitochondrial behavior during axon regeneration/degeneration in vivo. Neurosci Res 139:42–47. https://doi.org/10.1016/j.neures.2018.08.014
Kornberg MD, Bhargava P, Kim PM, Putluri V, Snowman AM, Putluri N, Calabresi PA, Snyder SH (2018) Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360:449–453. https://doi.org/10.1126/science.aan4665
Kremer D, Aktas O, Hartung HP, Küry P (2011) The complex world of oligodendroglial differentiation inhibitors. Ann Neurol 69:602–618. https://doi.org/10.1002/ana.22415
La Rocca C, Carbone F, De Rosa V, Colamatteo A, Galgani M, Perna F, Lanzillo R, Brescia Morra V, Orefice G, Cerillo I, Florio C, Maniscalco GT, Salvetti M, Centonze D, Uccelli A, Longobardi S, Visconti A, Matarese G (2017) Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration. Metabolism 77:39–46. https://doi.org/10.1016/j.metabol.2017.08.011
Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW, Pellerin L, Magistretti PJ, Rothstein JD (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487(7408):443–448. https://doi.org/10.1038/nature11314
Li C, Buettger C, Kwagh J, Matter A, Daikhin Y, Nissim IB, Collins HW, Yudkoff M, Stanley CA, Matschinsky FM (2004) A signaling role of glutamine in insulin secretion. J Biol Chem 279:13393–401. https://doi.org/10.1074/jbc.M311502200
Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Münch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481–487. https://doi.org/10.1038/nature21029
Lim CK, Bilgin A, Lovejoy DB, Tan V, Bustamante S, Taylor BV, Bessede A, Brew BJ, Guillemin GJ (2017) Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci Rep 7:41473. https://doi.org/10.1038/srep41473
Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Brück W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134:678–692. https://doi.org/10.1093/brain/awq386
Liu X, Cooper DE, Cluntun AA, Warmoes MO, Zhao S, Reid MA, Liu J, Lund PJ, Lopes M, Garcia BA, Wellen KE, Kirsch DG, Locasale JW (2018) Acetate production from glucose and coupling to mitochondrial metabolism in mammals. Cell 175(2):502-513.e13. https://doi.org/10.1016/j.cell.2018.08.040
Lorefice L, Murgia F, Fenu G, Frau J, Coghe G, Murru MR, Tranquilli S, Visconti A, Marrosu MG, Atzori L, Cocco E (2019) Assessing the metabolomic profile of multiple sclerosis patients treated with interferon beta 1a by 1H-NMR spectroscopy. Neurotherapeutics 16:797–807. https://doi.org/10.1007/s13311-019-00721-8
Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K, Guillemin GJ, Brew BJ (2017) Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology 112:373–388. https://doi.org/10.1016/j.neuropharm.2016.03.024
Lu F, Selak M, O’Connor J, Croul S, Lorenzana C, Butunoi C, Kalman B (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 177:95–103. https://doi.org/10.1016/s0022-510x(00)00343-9
Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–17. https://doi.org/10.1002/1531-8249(200006)47:6%3c707::aid-ana3%3e3.0.co;2-q
Lutz NW, Viola A, Malikova I, Confort-Gouny S, Audoin B, Ranjeva JP, Pelletier J, Cozzone PJ (2007) Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid. PLoS One 2:e595. https://doi.org/10.1371/journal.pone.0000595
Mächler P, Wyss MT, Elsayed M, Stobart J, Gutierrez R, von Faber-Castell A, Kaelin V, Zuend M, San Martín A, Romero-Gómez I, Baeza-Lehnert F, Lengacher S, Schneider BL, Aebischer P, Magistretti PJ, Barros LF, Weber B (2016) In vivo evidence for a lactate gradient from astrocytes to neurons. Cell Metab 23:94–102. https://doi.org/10.1016/j.cmet.2015.10.010
MacMullen C, Fang J, Hsu BY, Kelly A, de Lonlay-Debeney P, Saudubray JM, Ganguly A, Smith TJ, Stanley CA, Hyperinsulinism, hyperammonemia Contributing Investigators (2001) Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab 86:1782–1787. https://doi.org/10.1210/jcem.86.4.7414
Manzo E, Lorenzini I, Barrameda D, O'Conner AG, Barrows JM, Starr A, Kovalik T, Rabichow BE, Lehmkuhl EM, Shreiner DD, Joardar A, Liévens JC, Bowser R, Sattler R, Zarnescu DC (2019) Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife 8:e45114. https://doi.org/10.7554/eLife.45114
Mazuel L, Blanc J, Repond C, Bouchaud V, Raffard G, Déglon N, Bonvento G, Pellerin L, Bouzier-Sore AK (2017) A neuronal MCT2 knockdown in the rat somatosensory cortex reduces both the NMR lactate signal and the BOLD response during whisker stimulation. PLoS One 12:e0174990. https://doi.org/10.1371/journal.pone.0174990
McDonnell E, Crown SB, Fox DB, Kitir B, Ilkayeva OR, Olsen CA, Grimsrud PA, Hirschey MD (2016) Lipids reprogram metabolism to become a major carbon source for histone acetylation. Cell Rep 17:1463–1472. https://doi.org/10.1016/j.celrep.2016.10.012
McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8:913–919. https://doi.org/10.1038/ni1507
Mehrpour M, Kyani A, Tafazzoli M, Fathi F, Joghataie MT (2013) A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance. Magn Reson Chem 51:102–109. https://doi.org/10.1002/mrc.3915
Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, Kuchroo VK (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536–541. https://doi.org/10.1038/415536a
Moussallieh FM, Elbayed K, Chanson JB, Rudolf G, Piotto M, De Seze J, Namer IJ (2014) Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis. Mult Scler 20:558–565. https://doi.org/10.1177/1352458513504638
Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957. https://doi.org/10.1084/jem.20030896
Nakahara J, Aiso S, Suzuki N (2010) Autoimmune versus oligodendrogliopathy: the pathogenesis of multiple sclerosis. Arch Immunol Ther Exp (Warsz) 58:325–333. https://doi.org/10.1007/s00005-010-0094-x
Nijland PG, Molenaar RJ, van der Pol SM, van der Valk P, van Noorden CJ, de Vries HE, van Horssen J (2015) Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions. Acta Neuropathol Commun 3:79. https://doi.org/10.1186/s40478-015-0261-8
O’Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29:4200–4209. https://doi.org/10.1523/JNEUROSCI.5032-08.2009
Obermeier B, Daneman R, Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19:1584–1596. https://doi.org/10.1038/nm.3407
Oh J, Vidal-Jordana A, Montalban X (2018) Multiple sclerosis: clinical aspects. Curr Opin Neurol 31:752–759. https://doi.org/10.1097/WCO.0000000000000622
Orihuela R, McPherson CA, Harry GJ (2016) Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 173:649–665. https://doi.org/10.1111/bph.13139
Park J, Choi H, Min JS, Park SJ, Kim JH, Park HJ, Kim B, Chae JI, Yim M, Lee DS (2013) Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J Neurochem 127:221–232. https://doi.org/10.1111/jnc.12361
Park SJ, Kim JK, Kim HH, Yoon BA, Ji DY, Lee CW, Kim HJ, Kim KH, Shin HY, Park SJ, Lee DY (2019) Integrative metabolomics reveals unique metabolic traits in Guillain-Barré Syndrome and its variants. Sci Rep 9:1077. https://doi.org/10.1038/s41598-018-37572-w
Pieragostino D, D’Alessandro M, di Ioia M, Rossi C, Zucchelli M, Urbani A, Di Ilio C, Lugaresi A, Sacchetta P, Del Boccio P (2015) An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis. Mol Biosyst 11:1563–1572. https://doi.org/10.1039/c4mb00700j
Poddighe S, Murgia F, Lorefice L, Liggi S, Cocco E, Marrosu MG, Atzori L (2017) Metabolomic analysis identifies altered metabolic pathways in multiple sclerosis. Int J Biochem Cell Biol 93:148–155. https://doi.org/10.1016/j.biocel.2017.07.004
Podlecka-Piętowska A, Kacka A, Zakrzewska-Pniewska B, Nojszewska M, Zieminska E, Chalimoniuk M, Toczylowska B (2019) Altered cerebrospinal fluid concentrations of hydrophobic and hydrophilic compounds in early stages of multiple sclerosis-metabolic profile analyses. J Mol Neurosci 69:94–105. https://doi.org/10.1007/s12031-019-01336-6
Porter RK, Brand MD (1995) Mitochondrial proton conductance and H+/O ratio are independent of electron transport rate in isolated hepatocytes. Biochem J 310:379–382. https://doi.org/10.1042/bj3100379
Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179:292–311. https://doi.org/10.1016/j.cell.2019.08.053
Prodinger C, Bunse J, Krüger M, Schiefenhövel F, Brandt C, Laman JD, Greter M, Immig K, Heppner F, Becher B, Bechmann I (2011) CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. https://doi.org/10.1007/s00401-010-0774-y
Raefsky SM, Mattson MP (2017) Adaptive responses of neuronal mitochondria to bioenergetic challenges: roles in neuroplasticity and disease resistance. Free Radic Biol Med 102:203–216. https://doi.org/10.1016/j.freeradbiomed.2016
Rangaraju V, Calloway N, Ryan TA (2014) Activity-driven local ATP synthesis is required for synaptic function. Cell 156:825–835. https://doi.org/10.1016/j.cell.2013.12.042
Reinke SN, Broadhurst DL, Sykes BD, Baker GB, Catz I, Warren KG, Power C (2014) Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis. Mult Scler 20:1396–1400. https://doi.org/10.1177/1352458513516528
Rinholm JE, Hamilton NB, Kessaris N, Richardson WD, Bergersen LH, Attwell D (2011) Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci 31:538–548. https://doi.org/10.1523/JNEUROSCI.3516-10.2011
Rone MB, Cui QL, Fang J, Wang LC, Zhang J, Khan D, Bedard M, Almazan G, Ludwin SK, Jones R, Kennedy TE, Antel JP (2016) Oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival. J Neurosci 36:4698–4707. https://doi.org/10.1523/JNEUROSCI.4077-15.2016
Royds JA, Timperley WR, Taylor CB (1981) Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change. J Neurol Neurosurg Psychiatry 44:1129–1135. https://doi.org/10.1136/jnnp.44.12.1129
Saxton WM, Hollenbeck PJ (2012) The axonal transport of mitochondria. J Cell Sci 125:2095–2104. https://doi.org/10.1242/jcs.053850
Schousboe A (2019) Metabolic signaling in the brain and the role of astrocytes in control of glutamate and GABA neurotransmission. Neurosci Lett 689:11–13. https://doi.org/10.1016/j.neulet.2018.01.038
Shao Y, Ye G, Ren S, Piao HL, Zhao X, Lu X, Wang F, Ma W, Li J, Yin P, Xia T, Xu C, Yu JJ, Sun Y, Xu G (2018) Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer. Int J Cancer 143:396–407. https://doi.org/10.1002/ijc.31313
Sheng ZH (2014) Mitochondrial trafficking and anchoring in neurons: New insight and implications. J Cell Biol 204:1087–1098. https://doi.org/10.1083/jcb.201312123
Sheng ZH (2017) The interplay of axonal energy homeostasis and mitochondrial trafficking and anchoring. Trends Cell Biol 27:403–416. https://doi.org/10.1016/j.tcb.2017.01.005
Simone IL, Federico F, Trojano M, Tortorella C, Liguori M, Giannini P, Picciola E, Natile G, Livrea P (1996) High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. J Neurol Sci 144:182–190. https://doi.org/10.1016/s0022-510x(96)00224-9
Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PM, Rauz S, Young SP (2010) NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases–a diagnostic tool? NMR Biomed 23:123–132. https://doi.org/10.1002/nbm
Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35. https://doi.org/10.1007/s00401-009-0619-8
Stanley CA, Fang J, Kutyna K, Hsu BY, Ming JE, Glaser B, Poncz M (2000) Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene HI/HA contributing investigators. Diabetes 49:667–73. https://doi.org/10.2337/diabetes.49.4.667
Steen G, Ransnäs L (1983) Organic acids or urine in multiple sclerosis. Acta Neurol Scand 68:231–40. https://doi.org/10.1111/j.1600-0404.1983.tb04831.x
Sternberg Z, Leung C, Sternberg D, Li F, Karmon Y, Chadha K, Levy E (2013) The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients. CNS Neurol Disord Drug Targets 12:104–11. https://doi.org/10.2174/1871527311312010016
Stoessel D, Stellmann JP, Willing A, Behrens B, Rosenkranz SC, Hodecker SC, Stürner KH, Reinhardt S, Fleischer S, Deuschle C, Maetzler W, Berg D, Heesen C, Walther D, Schauer N, Friese MA, Pless O (2018) Metabolomic profiles for primary progressive multiple sclerosis stratification and disease course monitoring. Front Hum Neurosci 12:226. https://doi.org/10.3389/fnhum.2018.00226
Sun T, Qiao H, Pan PY, Chen Y, Sheng ZH (2013) Motile axonal mitochondria contribute to the variability of presynaptic strength. Cell Rep 4:413–419. https://doi.org/10.1016/j.celrep.2013.06.040
Sylvestre DA, Slupsky CM, Aviv RI, Swardfager W, Taha AY (2020) Untargeted metabolomic analysis of plasma from relapsing-remitting multiple sclerosis patients reveals changes in metabolites associated with structural changes in brain. Brain Res 1732:146589. https://doi.org/10.1016/j.brainres.2019.146589
Tanaka M, Shimizu Y (2017) Dimethyl fumarate in multiple sclerosis. Brain Nerve 69(9):1041–1046. https://doi.org/10.11477/mf.1416200864
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I et al (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study. Lancet 386:743–800. https://doi.org/10.1016/S0140-6736(15)60692-4
Warren SA, Warren KG (1982) Multiple sclerosis and diabetes mellitus: further evidence of a relationship. Can J Neurol Sci 9:415–419. https://doi.org/10.1017/s0317167100044322
Wens I, Dalgas U, Deckx N, Cools N, Eijnde BO (2014) Does multiple sclerosis affect glucose tolerance? Mult Scler 20:1273–1276. https://doi.org/10.1177/1352458513515957
Wentling M, Lopez-Gomez C, Park HJ, Amatruda M, Ntranos A, Aramini J, Petracca M, Rusielewicz T, Chen E, Tolstikov V, Kiebish M, Fossati V, Inglese M, Quinzii CM, Katz Sand I, Casaccia P (2019) A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis. Brain 142:2756–2774. https://doi.org/10.1093/brain/awz201
Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50:169–80. https://doi.org/10.1002/ana.1077
Witte ME, Bø L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, van der Valk P, van Horssen J (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219:193–204. https://doi.org/10.1002/path.2582
Wuolikainen A, Jonsson P, Ahnlund M, Antti H, Marklund SL, Moritz T, Forsgren L, Andersen PM, Trupp M (2016) Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson’s disease and control subjects. Mol Biosyst 12:1287–1298. https://doi.org/10.1039/c5mb00711a
Wyss MT, Magistretti PJ, Buck A, Weber B (2011) Labeled acetate as a marker of astrocytic metabolism. J Cereb Blood Flow Metab 31:1668–1674. https://doi.org/10.1038/jcbfm.2011.84
Yan H, Rivkees SA (2006) Hypoglycemia influences oligodendrocyte development and myelin formation. Neuroreport 17:55–59. https://doi.org/10.1097/01.wnr.0000192733.00535.b6
Yang C, Sudderth J, Dang T, Bachoo RM, McDonald JG, DeBerardinis RJ (2009) Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res 69:7986–7993. https://doi.org/10.1158/0008-5472.CAN-09-2266
Zeinstra E, Wilczak N, De Keyser J (2000) [3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain. Neurosci Lett 289:75–77. https://doi.org/10.1016/s0304-3940(00)01254-4
Zhenyukh O, González-Amor M, Rodrigues-Diez RR, Esteban V, Ruiz-Ortega M, Salaices M, Mas S, Briones AM, Egido J (2018) Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation. J Cell Mol Med 22:4948–4962. https://doi.org/10.1111/jcmm.13759
Zhou P, Guan T, Jiang Z, Namaka M, Huang QJ, Kong JM (2018) Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stresses. CNS Neurosci Ther 24:126–134. https://doi.org/10.1111/cns.12782
Acknowledgements
This study was supported by Grants (NRF-2018R1D1A1B07050426 to S.J.P; NRF-2020R1A6A1A03043708 to S.J.P and J.W.C.) of the National Research Foundation (NRF) of Korea.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors report no conflicts of interest in this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Park, S.J., Choi, J.W. Brain energy metabolism and multiple sclerosis: progress and prospects. Arch. Pharm. Res. 43, 1017–1030 (2020). https://doi.org/10.1007/s12272-020-01278-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-020-01278-3